United Therapeutics Corpo... (UTHR)
NASDAQ: UTHR
· Real-Time Price · USD
312.86
0.80 (0.26%)
At close: Aug 15, 2025, 3:59 PM
313.13
0.09%
After-hours: Aug 15, 2025, 05:27 PM EDT
United Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 798.6M | 794.4M | 735.9M | 748.9M | 714.9M | 677.7M | 614.7M | 609.4M | 596.5M | 506.9M | 491.5M | 516M | 466.9M | 461.9M | 415.2M | 444.7M | 446.5M | 379.1M |
Cost of Revenue | 87.6M | 92.5M | 75.9M | 83.1M | 77.8M | 72.9M | 71M | 70.1M | 64.1M | 52.3M | 55.9M | 37.2M | 29.7M | 25.9M | 34.6M | 27.7M | 37.2M | 23M |
Gross Profit | 711M | 701.9M | 660M | 665.8M | 637.1M | 604.8M | 543.7M | 539.3M | 532.4M | 454.6M | 435.6M | 478.8M | 437.2M | 436M | 380.6M | 417M | 409.3M | 356.1M |
Operating Income | 364.5M | 382.8M | 357.7M | 343.1M | 319.9M | 356.3M | 260.1M | 327M | 313.4M | 284.4M | 175.6M | 314.3M | 201.8M | 288M | 169.8M | 228.7M | 222.2M | -64.8M |
Interest Income | 51.3M | 51.1M | 49.3M | 49.8M | 46.2M | 53.8M | 51M | 45.3M | 37.2M | 29.2M | 20.8M | 13.3M | 6.8M | 4.3M | 4.2M | 3.8M | 4M | 4.7M |
Pretax Income | 408.4M | 423.5M | 396.5M | 388.6M | 355.3M | 398.6M | 295.4M | 351.8M | 335.2M | 291.9M | 178.8M | 312.5M | 150.6M | 308.7M | 140.5M | 204.4M | 216.5M | 32.5M |
Net Income | 309.5M | 322.2M | 301.3M | 309.1M | 278.1M | 306.6M | 217.1M | 267.6M | 259.2M | 240.9M | 132.1M | 239.3M | 116M | 239.9M | 112.2M | 162.7M | 172.6M | 28.3M |
Selling & General & Admin | 190.8M | 170.1M | 162.5M | 219.2M | 177.6M | 144.4M | 132.2M | 127.6M | 130M | 87.3M | 166.1M | 98.4M | 141.5M | 79M | 127.9M | 109.1M | 112.8M | 117.2M |
Research & Development | 134M | 149M | 133.8M | 103.5M | 139.6M | 104.1M | 151.4M | 84.7M | 89M | 82.9M | 93.9M | 66.1M | 93.9M | 69M | 82.9M | 79.2M | 74.3M | 303.7M |
Other Expenses | 21.7M | n/a | 6M | n/a | n/a | n/a | n/a | n/a | -600K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 346.5M | 319.1M | 302.3M | 322.7M | 317.2M | 248.5M | 283.6M | 212.3M | 219M | 170.2M | 260M | 164.5M | 235.4M | 148M | 210.8M | 188.3M | 187.1M | 420.9M |
Interest Expense | 7.3M | 6.1M | 7.9M | 10.1M | 11.6M | 13.3M | 15.1M | 15.6M | 14.8M | 13.8M | 12.3M | 9.2M | 6.2M | 4.7M | 4.7M | 4.6M | 4.7M | 4.6M |
Selling & Marketing Expenses | 31M | 26.6M | 27M | 20.7M | 25.4M | 23.2M | 24.1M | 20.7M | 20.1M | 16.9M | 23M | 17.2M | 16.1M | 14.5M | 16.4M | 17.2M | 17.1M | 13.7M |
Cost & Expenses | 434.1M | 411.6M | 378.2M | 405.8M | 395M | 321.4M | 354.6M | 282.4M | 283.1M | 222.5M | 315.9M | 201.7M | 265.1M | 173.9M | 245.4M | 216M | 224.3M | 443.9M |
Income Tax Expense | 98.9M | 101.3M | 95.2M | 79.5M | 77.2M | 92M | 78.3M | 84.2M | 76M | 51M | 46.7M | 73.2M | 34.6M | 68.8M | 28.3M | 41.7M | 43.9M | 4.2M |
Shares Outstanding (Basic) | 45.1M | 44.9M | 45.2M | 44.6M | 44.4M | 47M | 47M | 46.9M | 46.9M | 46.3M | 45.8M | 48.7M | 48.1M | 47.69M | 45.1M | 44.9M | 44.8M | 44.6M |
Shares Outstanding (Diluted) | 48.3M | 48.6M | 48.7M | 48.4M | 47.5M | 49.7M | 49.8M | 49.7M | 49.5M | 49.6M | 49.4M | 48.7M | 48.1M | 47.7M | 47.8M | 47.6M | 47.3M | 46.4M |
EPS (Basic) | 6.86 | 7.18 | 6.74 | 6.93 | 6.26 | 6.52 | 4.62 | 5.71 | 5.53 | 5.20 | 2.88 | 4.91 | 2.41 | 5.03 | 2.49 | 3.62 | 3.85 | 0.63 |
EPS (Diluted) | 6.41 | 6.63 | 6.19 | 6.39 | 5.85 | 6.17 | 4.36 | 5.38 | 5.24 | 4.86 | 2.67 | 4.91 | 2.41 | 5.03 | 2.35 | 3.42 | 3.65 | 0.61 |
EBITDA | 436.8M | 382.8M | 424.1M | 417.8M | 338.6M | 426.9M | 324.2M | 340.3M | 326.3M | 319M | 198.1M | 334.6M | 169.5M | 300.5M | 181.8M | 221.4M | 234.6M | 49.6M |
EBIT | 415.7M | 417.4M | 404.4M | 398.7M | 319.9M | 411.9M | 310.5M | 327M | 313.4M | 305.7M | 184.9M | 321.7M | 156.8M | 288M | 169.2M | 209M | 222.2M | 37.1M |
Depreciation & Amortization | 21.1M | -34.6M | 19.7M | 19.1M | 18.7M | 15M | 13.7M | 13.3M | 12.9M | 13.3M | 13.2M | 12.9M | 12.7M | 12.5M | 12.6M | 12.4M | 12.4M | 12.5M |